Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease

Clinical trial NCT05575037 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05575037
Sponsor: Brigham and Women's Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nasal Polyps Asthma, Aspirin-Induced Aspirin-Exacerbated Respiratory Disease Aspirin-Sensitive Asthma With Nasal Polyps

Start date: 2023-08-01
Primary completion: 2026-04-30
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.